Intracranial Stents Market: Regional markets, technology, types, and applications

Intracranial stents are used for brain aneurysms and intracranial stenosis to open the blocked arteries. The use of intracranial stents is relatively new for these conditions, and long-term enhanced results of the placement of these stents alone is still under investigation. However, various studies have proved the potential of placement of these stents to reduce the risk of stroke in patients with intracranial stenosis as compared to medical therapy alone. An intracranial stent refers to a tubular structure that is placed inside the canal, duct, or blood vessel. It is used to provide relief from obstruction. It allows continuous flow of the fluid. Based on design, intracranial stents can be segmented into closed-cell and open-cell. In terms of type, intracranial stents can be classified into Solitaire, Neuroform, Enterprise, Wingspan, and Leo Plus. Physical features, dimensions, and functional characteristics vary between different types of intracranial stents. Wingspan is commonly used for the treatment of intracranial atherosclerotic diseases; whereas, Solitaire, Neuroform, Enterprise, and Leo Plus assist in coiling.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46416

The global intracranial stents market is expected to expand at a rapid pace due to factors such as increase in prevalence of brain aneurysms and strokes, government programs to decrease the burden of traumatic brain injury, technological advancements plugging treatment gaps, and availability of reimbursement. However, high cost of intracranial stents and stringent government regulations are likely to negatively impact the market.

The global intracranial stents market can be segmented based on product, disease indication, end-user, and geography. Based on product, the global intracranial stents market can be classified into self-expanding intracranial stents and embolization coil support intracranial stents. In terms of disease indication, the market can be classified into brain aneurysm and intracranial stenosis. Based on end- user, the global intracranial stents market can be categorized into hospitals and ambulatory surgical centers.

Read Report Overview: https://www.transparencymarketresearch.com/intracranial-stents-market.html

In terms of geography, the intracranial stents market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is sub-segmented into specific countries such as the U.S., Canada, the U.K., Germany, Brazil, China, India, and GCC countries. North America dominated the global intracranial stents market because of the presence of a large aging population and increased adoption of cranio maxillofacial implants in the region. In addition, technological advancements in the field of intracranial stents are driving demand for them in North America. The intracranial stents market in Asia, followed by that in Europe, is expected to expand at a significant rate in the next few years. China and India are expected to be rapidly expanding countries of the intracranial stents market in Asia.

Request Table of Content: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=46416

Key players operating in the global intracranial stents market are Covidien Ltd, DePuy Synthes Companies, MicroPort Scientific Corporation, Medtonic, OBEX Medical Limited, and Stryker Corporation. Some of the other companies with a significant presence in the global intracranial stents market include Abbott Laboratories, Balt Extrusion S.A., Admedes Schuessler GmbH, Cardiatis, S.A, and Penumbra, Inc. Companies are adopting different strategies, such as providing FDA-approved on-site training, strategic collaborations, and technology upgrades in order to increase their market presence and engage with customers. For instance, in January 2018, Stryker announced the positive results of WEAVE, the post market surveillance study of the company's Wingspan stent system, for patients suffering from intracranial atherosclerotic disease (ICAD).

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.